Effects of prenatal opioid exposure on infant sympathetic and parasympathetic nervous system activity

Alexandra R Tabachnick1, Rina Das Eiden2, Madelyn H Labella3

  • 1Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.

Psychophysiology
|October 27, 2023
PubMed

Insights

Prenatal opioid exposure impacts infant autonomic nervous system (ANS) function at six months. Opioid agonist therapy (OAT) and other opioids show unique effects on ANS regulation, influencing stress response development.

Area of Science:

  • Neuroscience
  • Developmental Psychology
  • Pediatrics

Background:

  • Prenatal opioid exposure is linked to infant developmental issues, including autonomic nervous system (ANS) dysregulation.
  • Limited research exists on long-term ANS effects beyond early infancy, considering both sympathetic and parasympathetic branches, and co-exposures.

Purpose of the Study:

  • To investigate the effects of prenatal opioid agonist therapy (OAT) and other opioid exposures on infant ANS activity.
  • To assess ANS responses at rest and during a social stressor (Still-Face Paradigm) at six months of age.

Main Methods:

  • Studied 86 infants with varying prenatal opioid and substance exposures.
  • Measured infant autonomic nervous system activity using physiological markers.
  • Utilized the Still-Face Paradigm to elicit a social stress response.

Main Results:

  • Prenatal exposure to OAT and other opioids demonstrated distinct impacts on infant ANS activity.
  • Effects varied based on opioid subtype (methadone vs. buprenorphine) and gestational timing.
  • Observed differences in ANS regulation at rest and during the social stressor.

Conclusions:

  • Prenatal opioid exposure has lasting, specific effects on infant autonomic nervous system development.
  • Understanding these effects is crucial for addressing developmental challenges in affected infants.
  • Findings inform models of the developing infant stress response system.

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
636
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
939
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
311
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K